Kidney Stone Market: Information by Type (Uric Acid, Struvite Kidney Stones, Cystine Stones) Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy), Diagnosis— Forecast Till 2026

Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Kidney Stone Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Type

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Calcium Oxalate Stones

4.3       Uric Acid

4.4       Struvite Kidney Stones

4.5       Cystine Stones

4.6       Calcium Phosphate Stones

5.         By Treatment Type   

5.1       Introduction

5.1.1    Market Size & Forecast (Value)

5.2       Medications

5.3       Extracorporeal Shock Wave Lithotripsy

5.4       Ureteroscopy

5.5       Percutaneous Nephrolithotomy

6          By Regional Overview          

6.1       Introduction 

6.1.1    Market Size & Forecast (Value)         

6.2       America         

6.2.1    North America           

6.2.1.1 U.S.     

6.2.1.1.1          By Type          

6.2.1.1.2          By Treatment Type    

6.2.1.2 Canada           

6.2.1.2.1          By Type          

6.2.1.2.2          By Treatment Type    

6.2.1.3 Mexico           

6.2.1.3.1          By Type          

6.2.1.3.2          By Treatment Type    

6.2.2    South America

6.2.2.1            By Type

6.2.2.2            By Treatment Type

6.3       Europe           

6.3.1    Market Size & Forecast (Value)         

6.3.2    Western Europe

6.3.2.1      Germany    

6.3.2.1.1          By Type          

8.3.2.1.2           By Treatment Type    

6.3.2.2      France        

6.3.2.2.1          By Type          

6.3.2.2.2           By Treatment Type    

6.3.2.3      U.K 

6.3.2.3.1          By Type          

6.3.2.3.2          By Treatment Type    

6.3.2.4      Italy

6.3.2.4.1          By Type          

6.3.2.4.2          By Treatment Type    

6.3.2.5      Spain          

6.3.2.5.1          By Type          

6.3.2.5.2          By Treatment Type    

6.3.2.6      Rest of Western Europe    

6.3.2.6.1          By Type

6.3.2.6.2          By Treatment Type

6.3.3    Eastern Europe

6.4       Asia Pacific    

6.4.1    Market Size & Forecast (Value)         

6.4.2    China  

6.4.2.1              By Type

6.4.2.2              By Treatment Type

6.4.3    India

6.4.3.1              By Type

6.4.3.2              By Treatment Type

6.4.4    Japan  

6.4.4.1              By Type          

6.4.4.2              By Treatment Type    

6.4.5    South Korea    

6.4.5.1              By Type          

6.4.5.2              By Treatment Type    

6.4.6    Australia         

6.4.6.1             By Type          

6.4.6.2             By Treatment Type    

6.4.      Rest of Asia-Pacific    

6.4.7.1              By Type         

6.4.6.2              By Treatment Type    

6.5       Middle East & Africa

6.5.1    Market Size & Forecast (Value)         

6.5.2    The Middle East

6.5.2.1      Saudi Arab

6.5.2.1.1          By Type          

6.5.2.1.2          By Treatment Type    

6.5.2.2      UAE

6.5.2.2.1          By Type         

6.5.2.2.2          By Treatment Type    

6.5.2.3      Qatar

6.5.2.3.1          By Type         

6.5.2.3.2          By Treatment Type    

6.5.2.4      Rest of Middle East

6.5.2.4.1          By Type

6.5.2.4 2          By Treatment Type

6.6       Africa

6.6.1         By Type      

6.6.2         By Treatment Type

7.         Company Profile                  

7.1       Boston Scientific Corporation

7.1.1    Company Overview   

7.1.2    Financial Performance          

7.1.3    Recent Developments

7.1.4    Product Portfolio        

7.2       Convergent Laser Technologies        

7.2.1    Company Overview   

7.2.2    Financial Performance          

7.2.3    Recent Developments

7.2.4    Product Portfolio        

7.3       DirexGroup

7.3.1    Company Overview   

7.3.2    Financial Performance          

7.3.3    Recent Developments

7.3.4    Product Portfolio        

7.4       Siemens Healthcare GmbH

7.4.1    Company Overview   

7.4.2    Financial Performance          

7.4.3    Recent Developments

7.4.4    Product Portfolio        

7.5       C.R. Bard Inc

7.5.1    Company Overview   

7.5.2    Financial Performance          

7.5.3    Recent Developments

7.5.4    Product Portfolio        

7.6       Cook Medical Inc       

7.6.1    Company Overview   

7.6.2    Financial Performance          

7.6.3    Recent Developments

7.6.4    Product Portfolio        

7.7       Dornier MedTech GmbH

7.7.1    Company Overview   

7.7.2    Financial Performance          

7.7.3    Recent Developments

7.7.4    Product Portfolio        

7.8       Richard Wolf Medical Instruments Corporation

7.8.1    Company Overview   

7.8.2    Financial Performance          

7.8.3    Recent Developments

7.8.4    Product Portfolio        

7.9       Olympus Corporation

7.9.1    Company Overview   

7.9.2    Financial Performance          

7.9.3    Recent Developments

7.9.4    Product Portfolio        

7.10     Stryker Corporation

7.10.1  Company Overview   

7.10.2  Financial Performance          

7.10.3  Recent Developments

7.10.4  Product Portfolio

Report Description Download Sample

Copyright . All rights Reserved By Straits Research